Monoclonal antibody of 100 µl targeting IDH1 for ICC, WB.
| Product Specifications | |
| Application | ICC, WB |
| Reactivity | Human, Hamster |
| Clonality | Monoclonal IgG2a ĸ |
| Host | Rat |
| Gene ID - Human | |
| Formulation | 1 mg/mL in PBS containing 50% glycerol. No preservative is contained. |
| Citations for Anti-IDH1 (Human) mAb (Clone: RcMab-1) – 6 Found |
| Kaneko, Mika Kato; Tsujimoto, Yuta; Hozumi, Yasukazu; Goto, Kaoru; Kato, Yukinari. Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations. Monoclonal Antibodies In Immunodiagnosis And Immunotherapy. 2013;32(3):224-8. PubMed - Comments: Used in: WB |
| Kaneko, Mika Kato; Tsujimoto, Yuta; Hozumi, Yasukazu; Goto, Kaoru; Kato, Yukinari. Novel monoclonal antibodies GMab-r1 and LMab-1 specifically recognize IDH1-R132G and IDH1-R132L mutations. Monoclonal Antibodies In Immunodiagnosis And Immunotherapy. 2013;32(3):224-8. PubMed - Comments: Used in: ICC |
| Kato, Yukinari; Natsume, Atsushi; Kaneko, Mika Kato. A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation. Biochemical And Biophysical Research Communications. 2013;432(4):564-7. PubMed - Comments: Used in: WB |
| Ogasawara, Satoshi; Kaneko, Mika Kato; Tsujimoto, Yuta; Liu, Xing; Kato, Yukinari. Multi-specific monoclonal antibody MsMab-2 recognizes IDH1-R132L and IDH2-R172M mutations. Monoclonal Antibodies In Immunodiagnosis And Immunotherapy. 2013;32(6):377-81. PubMed - Comments: Used in: WB |
| Liu, Xing; Kato, Yukinari; Kaneko, Mika Kato; Sugawara, Masato; Ogasawara, Satoshi; Tsujimoto, Yuta; Naganuma, Yasushi; Yamakawa, Mitsunori; Tsuchiya, Takashi; Takagi, Michiaki. Isocitrate dehydrogenase 2 mutation is a frequent event in osteosarcoma detected by a multi-specific monoclonal antibody MsMab-1. Cancer Medicine. 2013;2(6):803-14. PubMed - Comments: Used in: WB |
| Ikota, Hayato; Nobusawa, Sumihito; Arai, Hideo; Kato, Yukinari; Ishizawa, Keisuke; Hirose, Takanori; Yokoo, Hideaki. Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies. Brain Tumor Pathology. 2015;32(4):237-44. PubMed - Comments: Used in: IHC |